ELCRX
Price
$41.70
Change
-$0.08 (-0.19%)
Updated
Jun 2 closing price
Net Assets
462.37M
RGACX
Price
$85.14
Change
-$0.28 (-0.33%)
Updated
Jun 2 closing price
Net Assets
337.53B
Interact to see
Advertisement

ELCRX vs RGACX

Header iconELCRX vs RGACX Comparison
Open Charts ELCRX vs RGACXBanner chart's image
ELCRX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
ELCRX vs. RGACX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELCRX is a Buy and RGACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 338B vs. ELCRX (462M). ELCRX (0.00) and RGACX (0.00) have matching dividends . ELCRX was incepted earlier than RGACX: ELCRX (17 years) vs RGACX (24 years). ELCRX (1.29) is less costly to investors than RGACX (0.93). RGACX is a more actively managed with annual turnover of: 32.00 vs. ELCRX (20.00). RGACX has a lower initial minimum investment than ELCRX: RGACX (250) vs ELCRX (1000). RGACX annual gain was more profitable for investors over the last year : 13.40 vs. ELCRX (6.75). RGACX return over 5 years is better than : 20.76 vs. ELCRX (13.59).
ELCRXRGACXELCRX / RGACX
Total Expense Ratio1.290.93139%
Annual Report Gross Expense Ratio1.290.93139%
Fund Existence17 years24 years-
Gain YTD9.0869.92992%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets462M338B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.7513.4050%
Returns for 3 years37.3950.5874%
Returns for 5 years13.5920.7665%
Returns for 10 years91.30107.1185%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVR10.250.50
+5.13%
Chicago Rivet & Machine Co
WHG16.660.65
+4.06%
Westwood Holdings Group
EXPE226.37-2.00
-0.88%
Expedia Group
GPI308.32-3.19
-1.02%
Group 1 Automotive
ETON27.34-1.34
-4.67%
Eton Pharmaceuticals